What does Galaxy Diagnostics do?

Galaxy Diagnostics, Inc. is an infectious disease diagnostics company focused on advanced testing for flea and tick-borne diseases in humans and pets. Founded from the One Health Research Program at North Carolina State University, the company is led by experts in Bartonella and vector-borne diseases. Headquartered in Durham, North Carolina, Galaxy Diagnostics employs fewer than 25 people and operates as a privately held entity. The company’s mission is to provide healthcare providers with precise diagnostics that enhance treatment decisions and improve patient outcomes. Galaxy Diagnostics offers a range of testing services, including the Bartonella Digital ePCR™, which is a highly sensitive blood-based DNA test for detecting Bartonella, and the Lyme Borrelia Nanotrap Antigen Test for Lyme disease. They also provide comprehensive testing for various stealth pathogens, including Babesia and Borrelia. Their services cater to leading functional and integrative healthcare providers, as well as veterinary professionals, ensuring support throughout the testing process.